Moreover, we performed survival analyses and found that CRC patients with higher DSN1 expression exhibited significantly lower overall survival (P = 0.049) and higher risk of death (HR = 2.7) (Fig. 4H). This evidence concerns the gene DSN1 and colorectal carcinoma.